From professional translators, enterprises, web pages and freely available translation repositories.
cyamemezine, sulpiride, sultopride, amisulpride, tiapride, pimozide, halopéridol, dropéridol),
losartan/ hydrochlorothiazide is administered with medicinal products affected by serum potassium disturbances (e. g. digitalis glycosides and antiarrhythmics) and with the following torsades de pointes
clozapine halopéridol chlorpromazine mésoridazine phénothiazines sertindole sultopride thioridazine ziprasidone (saquinavir/ritonavir)
clozapine haloperidol chlorpromazine mesoridazine phenothiazines sertindole sultopride thioridazine ziprasidone (saquinavir/ritonavir)
trifluopérazine, cyamémazine, sulpiride, sultopride, amisulpride, tiapride, pimozide, halopéridol, dropéridol).
cyamemazine, sulpiride, sultopride, amisulpride, tiapride, pimozide, haloperidol, droperidol)
les neuroleptiques (par exemple phénothiazines, sertindole, sultopride, chlorpromazine, halopéridol, mésoridazine, pimozide ou thioridazine), antidépresseurs.
neuroleptics (e.g. phenothiazines, sertindole, sultopride, chlorpromazine, haloperidol, mesoridazine, pimozide, or thioridazine), antidepressive agents.
. autres médicaments: astémizole, érythromycine, quinine, chloroquine, halofantrine, pentamidine, probucol, terfénadine, vincamine, quelques antidépresseurs tricycliques, certains neuroleptiques (par exemple sultopride, phénothiazines): risque de torsades de pointes par allongement de l'intervalle qtc (addition des effets électrophysiologiques).
. other drugs: astemizole, erythromycin, quinine, chloroquine, halofantrine, pentamidine, probucol, terfenadine, vincamine, some tricyclic antidepressants, some neuroleptics (e. g. sultopride, phenothiazines): risk of torsades de pointes due to prolongation of the q-tc interval (additive electrophysiologic effects).